https://www.selleckchem.com/pr....oducts/isoxazole-9-i
These results can expand the understanding of the phenomenon of movement awareness among physiotherapists, although further research is needed. To evaluate clinical and economic outcomes associated with valbenazine compared with deutetrabenazine in patients with tardive dyskinesia (TD) using a model that accounts for multiple dimensions of patient health status. A discretely integrated condition event model was developed to evaluate the cost-effectiveness of treatment with valbenazine and deutetrabenazine in a synthetic cohort
Like
Comment
Share
